Your browser doesn't support javascript.
loading
The Association for Human Pharmacology in the Pharmaceutical Industry London Meeting 2018: Brexit and Other Challenges in Early Phase Drug Development.
Reijntjes, Susan; Albayaty, Muna; Bush, James; Cheriyan, Joseph; Cromie, Anthea; Koch, Annelize; Hammond, Michael; Mair, Stuart; Scholes, Peter; Lorch, Ulrike; Stringer, Steffan; Taubel, Jorg; Hardman, Timothy C.
Afiliação
  • Reijntjes S; Niche Science & Technology Ltd., Richmond, United Kingdom.
  • Albayaty M; Parexel International, Northwick Park Hospital, London, United Kingdom.
  • Bush J; Covance Clinical Research Unit Ltd., Leeds, United Kingdom.
  • Cheriyan J; Cambridge University Hospital NHS Foundation Trust, Cambridge, United Kingdom.
  • Cromie A; Celerion, Belfast, United Kingdom.
  • Koch A; Simbec-Orion Group, Slough, United Kingdom.
  • Hammond M; Clinical Quality Management Solutions, Oxford, United Kingdom.
  • Mair S; Quotient Sciences, Nottingham, United Kingdom.
  • Scholes P; Quotient Sciences, Nottingham, United Kingdom.
  • Lorch U; Richmond Pharmacology Ltd., London, United Kingdom.
  • Stringer S; Alwyn Consulting, Guildford, United Kingdom.
  • Taubel J; Richmond Pharmacology Ltd., London, United Kingdom.
  • Hardman TC; Niche Science & Technology Ltd., Richmond, United Kingdom.
Front Pharmacol ; 9: 1301, 2018.
Article em En | MEDLINE | ID: mdl-30510508
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Risk_factors_studies Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Risk_factors_studies Idioma: En Ano de publicação: 2018 Tipo de documento: Article